Author:
Yoshiji Satoshi,Tanaka Daisuke,Minamino Hiroto,Lu Tianyuan,Butler-Laporte Guillaume,Murakami Takaaki,Fujita Yoshihito,Richards J. Brent,Inagaki Nobuya
Abstract
Previous studies reported associations between obesity measured by body mass index (BMI) and coronavirus disease 2019 (COVID-19). However, BMI is calculated only with height and weight and cannot distinguish between body fat mass and fat-free mass. Thus, it is not clear if one or both of these measures are mediating the relationship between obesity and COVID-19. Here, we used Mendelian randomization (MR) to compare the independent causal relationships of body fat mass and fat-free mass with COVID-19 severity. We identified single nucleotide polymorphisms associated with body fat mass and fat-free mass in 454,137 and 454,850 individuals of European ancestry from the UK Biobank, respectively. We then performed two-sample MR to ascertain their effects on severe COVID-19 (cases: 4,792; controls: 1,054,664) from the COVID-19 Host Genetics Initiative. We found that an increase in body fat mass by one standard deviation was associated with severe COVID-19 (odds ratio (OR)body fat mass = 1.61, 95% confidence interval [CI]: 1.28–2.04, P = 5.51 × 10-5; ORbody fat-free mass = 1.31, 95% CI: 0.99–1.74, P = 5.77 × 10-2). Considering that body fat mass and fat-free mass were genetically correlated with each other (r = 0.64), we further evaluated independent causal effects of body fat mass and fat-free mass using multivariable MR and revealed that only body fat mass was independently associated with severe COVID-19 (ORbody fat mass = 2.91, 95% CI: 1.71–4.96, P = 8.85 × 10-5 and ORbody fat-free mass = 1.02, 95%CI: 0.61–1.67, P = 0.945). In summary, this study demonstrates the causal effects of body fat accumulation on COVID-19 severity and indicates that the biological pathways influencing the relationship between COVID-19 and obesity are likely mediated through body fat mass.
Subject
Endocrinology, Diabetes and Metabolism
Reference45 articles.
1. WHO coronavirus (COVID–19) dashboard
2. Associations between body–mass index and COVID–19 severity in 6·9 million people in England: a prospective, community–based, cohort study;Gao;Lancet Diabetes Endocrinol,2021
3. Body mass index and risk of COVID–19 diagnosis, hospitalization, and death: A cohort study of 2 524 926 catalans;Recalde;J Clin Endocrinol Metab,2021
4. Characteristics and outcomes of 627 044 COVID–19 patients living with and without obesity in the united states, Spain, and the united kingdom;Recalde;Int J Obes (Lond),2021
5. Prevalence of obesity and its impact on outcome in patients with COVID–19: A systematic review and meta–analysis;Helvaci;Front Endocrinol (Lausanne),2021
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献